Safety, Tolerability and Pharmacokinetics of Injectable PEG-Irinotecan (JK-1201I) in Patients with Malignant Solid Tumor
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Solid Tumor
Related studies linked through entity extraction aliases.
A Feasibility Study for the Use of Multispectral Optoacoustic Tomography in the Detection of Tumors
- Status
- COMPLETED
- Phase
- NA
A Study to Find the MTD of SYN125 in People With Solid Tumors and the MTD of SYN125 With a Fixed Dose of SYN004 in People in Patients With Epithelial Cancers With EGFR Expressions
- Status
- UNKNOWN
- Phase
- PHASE1
Safety of the Combination of SH003 and Docetaxel in Patients With Solid Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
BA Study of IMP4297 (20mg vs 10mg) in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Study of ONCR-177 Alone and in Combination With PD-1 Blockade in Adult Subjects With Advanced and/or Refractory Cutaneous, Subcutaneous or Metastatic Nodal Solid Tumors or With Liver Metastases of Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19
- Status
- TERMINATED
- Phase
- PHASE2
Study to Evaluate the Efficacy and Safety of Camrelizumab and Famitinib in Patients With Advanced Solid Tumor
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study of IMC-002 in Subjects With Metastatic or Locally Advanced Solid Tumors and Relapsed or Refractory Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Preliminary Efficacy of ATG-017 Monotherapy or Combination Therapy With Nivolumab in Advanced Solid Tumors and Hematological Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Research for the Molecular Imaging of the PD-L1 Targeting Tracer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Prospective Study of the Relevance of the HLA-G Immune Checkpoint in Cancer Immunotherapy
- Status
- UNKNOWN
- Phase
- N/A
A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Efficacy and Safety of the Combination of Rucaparib (PARP Inhibitor) and Atezolizumab (Anti-PD-L1 Antibody) in Patients With DNA Repair-deficient or Platinum-sensitive Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2